Drug Shortage Report for BYSTOLIC
Report ID | 73787 |
Drug Identification Number | 02399016 |
Brand name | BYSTOLIC |
Common or Proper name | BYSTOLIC 10MG TAB 30 CA |
Company Name | ABBVIE CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | Nebivolol |
Strength(s) | 10.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 10MG TAB 30 |
ATC code | C07AB |
ATC description | BETA BLOCKING AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-01-29 |
Estimated end date | 2019-02-13 |
Actual end date | 2019-02-21 |
Shortage status | Resolved |
Updated date | 2019-02-22 |
Company comments | Packaging components delay at 3rd party packager. Other strengths including 5mg are available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-02-22 | English | Compare |
v5 | 2019-02-21 | French | Compare |
v4 | 2019-02-21 | English | Compare |
v3 | 2019-01-30 | English | Compare |
v2 | 2019-01-29 | French | Compare |
v1 | 2019-01-29 | English | Compare |
Showing 1 to 6 of 6